US EditionPublished • loading... • Updated
Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Lexaria Bioscience raised $3.5 million by selling 2,661,600 common shares at $1.315 each to fund research and operations, offering exercisable warrants for five years.
Summary by Mid Florida Newspapers
5 Articles
5 Articles
Mid Florida Newspapers+4 Reposted by 4 other sources
Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
KELOWNA, BC / ACCESS Newswire / December 16, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX, LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced the closing of its previously announced registered direct offering priced at-the-market under…
Coverage Details
Total News Sources5
Leaning Left2Leaning Right0Center1Last UpdatedBias Distribution67% Left
Bias Distribution
- 67% of the sources lean Left
67% Left
L 67%
C 33%
Factuality
To view factuality data please Upgrade to Premium
